Page last updated: 2024-11-04

sumatriptan and Erythremia

sumatriptan has been researched along with Erythremia in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research Excerpts

ExcerptRelevanceReference
"Migraines affect approximately 10% of the adult population worldwide."2.73A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. ( Dubé, LM; Jackson, D; Kaldeway, P; Morris, R; O'Neill, C; Sebree, T; Siegel, SJ, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siegel, SJ1
O'Neill, C1
Dubé, LM1
Kaldeway, P1
Morris, R1
Jackson, D1
Sebree, T1

Trials

1 trial available for sumatriptan and Erythremia

ArticleYear
A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.
    Pharmaceutical research, 2007, Volume: 24, Issue:10

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Chemistry, Pharmaceutical; Drug Delivery Sys

2007